STATEMENT OF THE BOARD OF DIRECTORS OF NEUCA S.A. regarding the decision of the President of the Office of Competition and Consumer Protection
2026-08-27
NEUCA with an over 45% growth rate of operating profit in the wholesale distribution of medicines segment in the second quarter of 2026
2026-05-21
One of the best ever financial performances for NEUCA in the first quarter of 2026
2026-03-26
NEUCA 2025: over PLN 158 m in adjusted net profit for shareholders of the Parent, the highest ever referral rate and an impressive market share in the segment of independent pharmacies
2025-11-20
In the third quarter, NEUCA reached an over 39% share in the market of independent pharmacies and over PLN 60 m in net profit attributable to shareholders of the Parent
NEUCA 2025: over PLN 158 m in adjusted net profit for shareholders of the Parent, the highest ever referral rate and an impressive market share in the segment of independent pharmacies
2025-11-20
In the third quarter, NEUCA reached an over 39% share in the market of independent pharmacies and over PLN 60 m in net profit attributable to shareholders of the Parent
NEUCA with an over 45% growth rate of operating profit in the wholesale distribution of medicines segment in the second quarter of 2026
2026-05-21
One of the best ever financial performances for NEUCA in the first quarter of 2026
2026-03-26
NEUCA 2025: over PLN 158 m in adjusted net profit for shareholders of the Parent, the highest ever referral rate and an impressive market share in the segment of independent pharmacies
2025-11-20
In the third quarter, NEUCA reached an over 39% share in the market of independent pharmacies and over PLN 60 m in net profit attributable to shareholders of the Parent